An inverted J-shaped association of serum uric acid with muscle strength among Japanese adult men: a cross-sectional study by Cong Huang et al.
Huang et al. BMC Musculoskeletal Disorders 2013, 14:258
http://www.biomedcentral.com/1471-2474/14/258RESEARCH ARTICLE Open AccessAn inverted J-shaped association of serum uric
acid with muscle strength among Japanese adult
men: a cross-sectional study
Cong Huang1, Kaijun Niu2, Yoritoshi Kobayashi1, Lei Guan1, Haruki Momma3, Yufei Cui1, Masahiro Chujo1,
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Background: Uric acid (UA) may protect muscle function from oxidative damage due to reactive oxygen species
through its powerful antioxidant capacity. However, several studies have demonstrated that hyperuricemia is closely
related to systemic inflammation and has oxidant properties effects, both of which may increase the risk of muscle
strength loss. The purpose of this study was to examine the association of serum UA concentration with grip
strength and leg extension power in adult men.
Methods: This study is a cross-sectional survey in which 630 Japanese male employees aged 30 years and older
participated. Five hundred and eighty-six subjects participated in the measurement of grip strength, and 355
subjects participated in the measurement of leg extension power. Blood samples were obtained for serum UA
analysis.
Results: After adjustment for potential confounders, grip strength differed significantly between participants with
and those without hyperuricemia (geometric mean and 95% confidence interval [CI]: 40.3 [39.2–41.3] kg vs. 41.9
[41.3–42.5] kg; P = 0.01). In addition, serum UA levels (quartiles) showed an inverted J-shaped curve with grip
strength (mean and 95% CI: Q1, 41.6 [40.6–42.6] kg; Q2, 42.2 [41.2–43.2] kg; Q3, 41.8 [40.8–42.8] kg; Q4, 40.4
[39.3–41.4] kg; P for quadratic trend = 0.05). The results in the leg extension power group were similar to those
observed in the grip strength group.
Conclusion: This population-based cross-sectional study shows for the first time that hyperuricemia is associated
with poor muscle strength. Moreover, the results indicate an inverted J-shaped association between serum UA
quartiles and muscle strength.
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Sarcopenia is defined as a gradual decline in skeletal
muscle mass with aging and is associated with poor
muscle strength [1]. Increasing evidence has demon-
strated that low muscle strength is a strong and consist-
ent predictor of mortality in middle-aged and elderly
persons [2-4]. One important contributing factor to the* Correspondence: nagatomi@med.tohoku.ac.jp
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reproduction in any medium, provided the ordevelopment of sarcopenia is postulated to be the accu-
mulation of reactive oxygen species (ROS), which may
cause the oxidative damage of protein and DNA in skel-
etal muscle [5].
Numerous antioxidants circulating in blood or present
in tissues may help reduce oxidative stress; however, of
these, uric acid (UA) has long been thought to be one of
the most important compounds involved in ROS re-
moval. Maxwell et al. [6] have implied that UA probably
accounts for more than half of the free radical–scaven-
ging capacity in serum. Specifically, UA can scavenge ox-
idants such as hydroxyl and peroxyl radicals and singlet
oxygen [7,8], and can prevent the generation of radicalsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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3-year follow-up study [10] reported that UA could posi-
tively influence skeletal muscle strength in the elderly,
probably by providing protection against oxidative stress.
In contrast to its role as an antioxidant, high concen-
trations of UA have also been considered a trigger for a
number of diseases. Hyperuricemia, usually defined as a
UA concentration of >7.0 mg/dL in men and >6.0 mg/
dL in women [11], is a risk factor for cardiovascular
disease, hypertension, diabetes, and kidney disease [12].
Additionally, serum UA might contribute to the inflam-
matory response and the subsequent inflammatory re-
lated diseases [13,14].
On the basis of studies conducted during the last 3 de-
cades, it is difficult to define UA as clearly beneficial
[7,10,15] or pathological [12]. Ruggiero et al. [16] reported
that the elderly in the middle serum UA quintile tended to
have less disability in instrumental activities of daily living
and higher physical performance as measured by walking
speed, standing balance and ability to rise from a chair,
than those with higher or lower UA levels. In fact, the
antioxidant compound UA can become a pro-oxidant in
specific environments, particularly when present in blood
at higher than normal levels [17].
In light of these observations, we hypothesize that low
or high serum UA concentration may be associated with
poor skeletal muscle strength. Therefore, the aim of the
present study was to investigate the association between
serum UA and muscle strength, i.e., grip strength and
leg extension power, in adult men.
Methods
Study population
This cross-sectional analysis was performed as part of
the Oroshisho Study, a study of lifestyle-related effects
on illnesses and health status in Japanese adults. In this
study, all of the 1263 participants were adult employees
and received an annual health examination at the Sendai
Oroshisho Center in Sendai, Japan, 2009. This study was
carried out from August 3 to 7. In addition to the annual
health examination, physical activities, daily nutrient in-
takes, and muscle strength were also assessed. Further de-
tails on the study have been provided elsewhere [18,19].
The analysis in current study was limited to partici-
pants who agreed to provide written informed consent
for their data to be analyzed (n = 1215, response rate =
96.2%). Subjects were excluded from the present study
for the following reasons: 1) being female (n = 282); 2)
having no UA data available (n = 136); 3) having a his-
tory of cardiovascular disease and renal failure, or using
antihypertensive, lipid-lowering, or antidiabetic agents
(n = 146) because of the concern that such diagnoses
and agents may lead to changes in UA levels and/or
muscular function and thus confound and obscure a trueassociation [19]; or 4) having no data on education level,
physical activity, depression symptoms, and diet (n = 21).
None of the participants had gout. With this population
sample, subjects with missing data on grip strength (n = 44)
or were not measured for leg extension power (n = 275)
were excluded from analyses. Finally, a total of 586 sub-
jects qualified for grip strength analysis and 355 subjects
qualified for leg extension power analysis. All research
procedures were consistent with the Declaration of
Helsinki for human rights [20]. Approval for this study
was obtained from the institutional review board of the
Tohoku University Graduate School of Medicine.
Measurement of serum UA
Blood samples were drawn from the antecubital vein in the
morning, after overnight fasting, while subjects were in the
sitting position; blood was collected into siliconized vacuum
glass tubes; and then the frozen serum was sent to Bio
Medical Laboratories (BML Inc., Sendai, Japan) for sub-
sequent measurement of blood components. Serum UA
levels were measured enzymatically by using a Pureauto S
UA kit (Sekisui Medical Co., Ltd., Tokyo, Japan); the lower
limit of detection was 0.2 mg/dL. UA levels were then di-
vided into quartiles based on the distribution: <5.4, 5.4–6.0,
6.1–6.8, and >6.8 mg/dL. Hyperuricemia was defined as a
serum UA level of ≥7.0 mg/dL for men [11].
Measurements of muscle strength
Grip strength in kilograms was assessed using a hand-
held digital Smedley dynamometer (TKK 5401; Takei
Scientific Instruments Co., Ltd, Niigata, Japan) in the
standing position. Participants were asked to hold the
dynamometer in a comfortable position and were not
allowed to see the figure displayed on the dial during the
trial. Grip strength was measured 4 times, twice for each
hand alternately, with a brief interval between trials. Par-
ticipants were encouraged to exert their maximal grip,
and the average value of the highest power of both
hands was recorded as the grip strength.
Leg extension power was determined with an isotonic
apparatus (Anaeropress 3500; Combi Co., Tokyo, Japan).
After warming up, the subjects sat back on the seat, placed
both feet on the sliding foot plate with the knee angle
adjusted to 90°, and then, the waist of each participant
was firmly fastened with belts. Participants were urged to
extend their feet with maximum effort. Five trials were
measured at 15-s intervals, and the maximal value was
recorded as the leg extension power (W/kg) for the ana-
lysis. The reliability and validity of the leg extension power
measurement was described in detail elsewhere [21].
Relevant covariates
Body mass index (BMI) was calculated as weight/height2
(kg/m2). Blood pressure was measured twice on the
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Kenzmedico, Saitama, Japan) while subjects were in the
sitting position, with a 5-min interval between measure-
ments. The mean of 2 measurements was used for the
current study. Information on age, sex, smoking status
(never, former, current), drinking frequency (every day,
sometimes, never), education levels (<college or ≥ college),
and occupation (desk-centric or not) were obtained using
a questionnaire survey.
The estimation of physical activity was determined
using the International Physical Activity Questionnaire
[22]. Total daily physical activities were calculated [22]
and divided into 2 categories, <23 and ≥23 metabolic
equivalent (MET) hours/week [23]. Assessment of daily
nutrient intake was made using a brief self-administered
diet history questionnaire (BDHQ) containing questions
about the consumption frequency of 75 principal foods
[24]. The reproducibility and validity of the BDHQ used
in this study were described in detail elsewhere [24]. The
metabolic syndrome was defined according to the cri-
teria of the American Heart Association Scientific State-
ments of 2009 for persons of Asian ethnicity (including
Japanese) [25]. The Japanese version of the Self-rating
Depression Scale was used to examine the severity of de-
pression subjectively [26]. Participants who scored ≥45
raw sum points were considered to have depression [27].
Serum high-sensitivity C-reactive protein (hs-CRP)
was measured with N-latex CRP-2 (Siemens Healthcare
Japan, Tokyo, Japan). The lower limit of detection was
0.02 mg/L, and the hs-CRP value was considered to be
0.01 mg/L when lower than the detection limit. Other
serum parameters were analyzed by enzymatic methods,
using appropriate kits for measuring the concentrations
of creatinine (Kainos, Tokyo, Japan), triglycerides, high-
density lipoprotein cholesterol (HDL-C) (Sekisui Med-
ical, Tokyo, Japan), and fasting blood glucose (Eurotec,
Tokyo, Japan). The estimated glomerular filtration rate
(eGFR) in men was calculated from the serum creatinine
level by using a new Japanese equation [28], in which the
glomerular filtration rate (mL⋅min-1⋅1.73 m-2) = 194 ×
serum creatinine − 1.094 × age − 0.287.
Statistical analyses
In this study, continuous variables were summarized as
geometric mean (95% confidence interval, CI) and cat-
egorical variables were summarized as percentages. Except
for leg extension power, all continuous variables were log-
transformed because of their abnormal distribution and
back-transformed for data presentation.
Analysis of covariance (ANCOVA) was conducted to
examine age-adjusted participant characteristics according
to serum UA levels. By ANCOVA analysis, differences in
muscle strength between subjects with and those without
hyperuricemia were analyzed after adjusting for potentialconfounders. The linear or quadratic trends between
serum UA quartiles and muscle strength were analyzed by
univariate (analysis of variance, ANOVA) and multivariate
analysis (ANCOVA). In multivariate analysis, adjustment
for age and BMI was performed in model 1. Model 2 was
adjusted for lifestyle-related factors, including smoking
status, drinking frequency, education levels, occupation,
physical activity, daily energy intakes, and protein intakes
in addition to the variables in model 1. Model 3 was ad-
justed for variables in model 2 and health status–related
factors such as metabolic syndrome, depressive symptoms,
and eGFR (renal function). Finally, model 4 was addition-
ally adjusted for the circulating inflammatory marker hs-
CRP. A significance level of P < 0.05 was used for 2-sided
tests. All tests were performed using IBM SPSS Statistics
19.0 software (IBM SPSS Inc., Chicago, IL, USA).
Results
Participant characteristics
The population sample consisted of 586 men for grip
strength analysis (mean age [SD]: 46.3 [9.3] years) and
355 men for leg extension power analysis (46.3 [9.5]
years). In both populations, the mean (SD) serum UA
value was 6.1 (1.2) mg/dL.
The age-adjusted associations between serum UA and
participant characteristics in the grip strength group are
presented in Table 1. The mean BMI, systolic blood
pressure, diastolic blood pressure, proportion of every-
day drinkers, serum hs-CRP, and triglyceride were sig-
nificantly and positively associated with the quartiles of
serum UA (P for linear trend <0.01, for all). In addition,
the prevalence of metabolic syndrome was higher across
the quartiles of serum UA (P for linear trend <0.01),
whereas the proportion of nonsmokers, former smokers,
never drinkers, and sometimes drinkers, and the eGFR
demonstrated a negative association with serum UA levels
(P for linear trend: 0.04, 0.01, 0.06, 0.06, and <0.01, re-
spectively). In contrast, the mean age; the proportion of
those who had education levels ≥ college, self-reported
physical activity ≥23 MET hours/week, and depressive
symptoms; the proportion of desk workers; HDL-C; and
fasting glucose did not differ significantly among the
serum UA quartiles. In addition, none of the nutrients ex-
amined demonstrated any statistically significant associa-
tions with serum UA levels.
The results of the main characteristics of participants
in the leg extension power group were approximately
equal to that of the grip strength group, with the excep-
tion of HDL-C and the proportion of never drinkers
(Table 2). In the leg extension power group, HDL-C was
found to be significantly lower across the serum UA
quartiles (P for linear trend = 0.01), whereas no associ-
ation between the proportion of never drinkers and UA
quartiles were observed.
Table 1 Age-adjusted participant characteristics according to serum UA levels in grip strength group (n = 586)
Serum UA quartiles, mg/dL P 1
<5.4 5.4–6.0 6.1–6.8 >6.8
Participants 152 144 145 145 ―
Age, years 46.4 (44.9–47.8) 2 45.3 (43.8–46.8) 45.1 (43.6–46.5) 45.0 (43.5–46.4) 0.18
BMI, kg/m2 22.7 (22.2–23.1) 22.9 (22.4–23.4) 23.2 (22.7–23.7) 24.8 (24.3–25.4) <0.01
Systolic blood pressure, mmHg 122 (120–124) 124 (122–126) 128 (126–131) 132 (130–135) <0.01
Diastolic blood pressure, mmHg 78 (77–80) 79 (77–80) 82 (80–84) 85 (84–87) <0.01
Education levels (≥college), % 33.6 31.3 37.9 32.4 0.91
Occupation (desk work), % 77.6 78.5 78.6 77.9 0.86
Smoking status
Never, % 38.2 38.9 35.9 26.9 0.04
Former, % 10.5 7.6 13.1 18.6 0.02
Current, % 51.3 53.5 51.0 54.5 0.75
Drinking frequency
Every day, % 17.8 32.6 31.0 37.2 <0.01
Sometimes, % 57.9 55.6 53.8 48.3 0.06
Never, % 24.3 11.8 15.2 14.5 0.05
Physical activity, MET hours/week
≥23, % 37.5 33.3 33.1 37.2 0.94
Metabolic syndrome, % 18.4 13.9 17.9 30.3 <0.01
Depressive symptoms, % 34.9 31.3 28.3 36.6 0.85
Daily nutrient intakes
Total energy, kcal 1819 (1728–1914) 1815 (1722–1912) 1855 (1761–1954) 1888 (1792–1989) 0.26
Protein, g 61.6 (58.1–65.2) 59.7 (56.3–63.4) 61.1 (57.6–64.8) 62.6 (59.0–66.4) 0.59
Vitamin C, mg 78.7 (71.7–86.4) 77.9 (70.7–85.7) 75.9 (69.0–83.5) 81.5 (74.0–89.6) 0.72
α-tocopherol, mg 6.3 (5.8–6.7) 6.2 (5.8–6.7) 6.4 (6.0–6.9) 6.5 (6.0–7.0) 0.48
β-carotene, μg 1897 (1660–2167) 1842 (1606–2112) 1967 (1716–2254) 2128 (1857–2439) 0.18
Blood characteristics
High-sensitivity CRP, mg/L 0.33 (0.28–0.39) 0.37 (0.31–0.45) 0.34 (0.29–0.41) 0.55 (0.46–0.65) <0.01
eGFR, mL⋅min-1⋅1.73 m-2 84.9 (83.1–86.9) 82.9 (81.0–84.8) 82.5 (80.7–84.4) 76.5 (74.8–78.3) <0.01
Triglyceride, mg/dL 97.1 (88.9–106) 106 (96.3–116) 115 (105–126) 137 (125–150) <0.01
HDL-C, mg/dL 52.9 (50.8–55.0) 50.9 (49.0–53.0) 52.0 (50.0–54.1) 50.1 (48.1–52.1) 0.16
Fasting glucose, mg/dL 97.1 (95.0–99.1) 94.2 (92.2–96.3) 94.3 (92.3–96.4) 95.0 (93.0–97.1) 0.20
1 The linear trends were obtained using ANCOVA for both continuous and categorical variables.
2 Variables have been log-transformed and expressed as geometric means (95% confidence interval).
Abbreviations: BMI body mass index, CRP C-reactive protein, eGFR estimated glomerular filtration rate, HDL-C high-density lipoprotein-cholesterol.
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In our study, grip strength differed significantly between
participants with and those without hyperuricemia (geo-
metric mean and 95% CI: 40.3 [39.2–41.3] kg vs. 41.9
[41.3–42.5] kg; P = 0.01) (Figure 1) after adjustment for
age, BMI, smoking status, drinking frequency, education
levels, occupation, physical activity, daily energy and
protein intakes, metabolic syndrome, depressive symp-
toms, eGFR, and hs-CRP. Similar results were obtained
when the leg extension power was compared, although
the result was statistically not significant (P = 0.09).Furthermore, we also investigated the association of
serum UA quartiles with muscle strength by using uni-
variate and multivariate analyses. In univariate analysis
(Figure 2), serum UA levels showed an inverted J-shaped
curve with grip strength (mean and 95% CI: Q1, 40.7
[39.7–41.8] kg; Q2, 42.0 [40.9–43.1] kg; Q3, 41.8 [40.7–
42.9] kg; Q4, 41.5 [40.4–42.5] kg; P for quadratic trend =
0.13) and leg extension power (Q1, 18.2 [17.2–19.1] W/
kg; Q2, 19.3 [18.4–20.3] W/kg; Q3, 18.9 [17.9–19.8] W/
kg; Q4, 18.0 [17.0–18.9] W/kg; P for quadratic trend =
0.03). The inverted J-shaped association between UA
Table 2 Age-adjusted participant characteristics according to serum UA levels in leg extension power group (n = 355)
Serum UA quartiles, mg/dL P 1
<5.4 5.4–6.0 6.1–6.8 >6.8
Participants 92 90 85 88 ―
Age, years 45.9 (44.1–47.9) 2 45.4 (43.6–47.4) 44.9 (43–46.8) 45.3 (43.4–47.3) 0.58
BMI, kg/m2 22.8 (22.2–23.4) 22.9 (22.3–23.5) 23.6 (23–24.3) 24.7 (24–25.3) <0.01
Systolic blood pressure, mmHg 122 (119–125) 122 (119–125) 128 (125–131) 131 (128–134) <0.01
Diastolic blood pressure, mmHg 78 (76–80) 77 (75–79) 82 (79–84) 83 (81–86) <0.01
Education levels (≥college), % 34.8 32.2 41.2 33.0 0.90
Occupation (desk work), % 80.4 77.8 75.3 78.4 0.69
Smoking status
Never, % 43.5 46.7 40.0 29.5 0.04
Former, % 12.0 7.8 15.3 18.2 0.11
Current, % 44.6 45.6 44.7 52.3 0.36
Drinking frequency
Every day, % 17.4 26.7 28.2 35.2 <0.01
Sometimes, % 58.7 62.2 54.1 46.6 0.05
Never, % 23.9 11.1 17.6 18.2 0.54
Physical activity, MET hours/week
≥23, % 41.3 30.0 31.8 37.5 0.72
Metabolic syndrome, % 16.3 13.3 22.4 29.5 <0.01
Depressive symptoms, % 37.0 30.0 28.2 35.2 0.78
Daily nutrient intakes
Total energy, kcal 1889 (1767–2019) 1772 (1657–1896) 1915 (1787–2053) 1947 (1819–2085) 0.27
Protein, g 63.8 (59.2–68.8) 58.6 (54.3–63.2) 63.8 (59.0–69.0) 65.0 (60.2–70.2) 0.42
Vitamin C, mg 84.0 (74.8–94.2) 78.5 (69.9–88.2) 79.8 (70.8–89.9) 88.0 (78.3–99.0) 0.55
α-tocopherol, mg 6.7 (6.1–7.3) 6.2 (5.6–6.8) 6.8 (6.2–7.4) 6.8 (6.2–7.5) 0.44
β-carotene, μg 2051 (1731–2430) 1812 (1527–2151) 2181 (1828–2601) 2224 (1870–2644) 0.27
Blood characteristics
High-sensitivity CRP, mg/L 0.28 (0.23–0.35) 0.37 (0.29–0.46) 0.32 (0.25–0.40) 0.48 (0.38–0.60) <0.01
eGFR, mL⋅min-1⋅1.73 m-2 84.1 (81.9–86.4) 82.2 (79.9–84.5) 82.5 (80.2–84.9) 77.2 (75.1–79.4) <0.01
Triglyceride, mg/dL 91.4 (82.1–102) 109 (98.2–122) 111 (99.3–124) 129 (116–144) <0.01
HDL-C, mg/dL 54.5 (51.9–57.3) 51.1 (48.6–53.7) 51.7 (49.1–54.4) 49.5 (47.1–52.0) 0.01
Fasting glucose, mg/dL 94.8 (92.8–97.0) 93.7 (91.6–95.8) 94.5 (92.3–96.7) 94.8 (92.6–96.9) 0.90
1 The linear trends were obtained using ANCOVA for both continuous and categorical variables.
2 Variables have been log-transformed and expressed as geometric means (95% confidence interval).
Abbreviations: BMI body mass index, CRP C-reactive protein, eGFR estimated glomerular filtration rate, HDL-C high-density lipoprotein-cholesterol.
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1 = 0.07, model 2 = 0.09, model 3 = 0.04, and model 4 =
0.05, respectively) and leg extension power (P for quad-
ratic trend: model 1 = 0.06, model 2 = 0.05, model 3 = 0.03,
and model 4 = 0.03, respectively) were unchanged even
after adjustment for potential confounding factors, in-
cluding age, BMI, smoking status, drinking frequency,
education levels, occupation, physical activity, daily en-
ergy and protein intakes, metabolic syndrome, depres-
sive symptoms, eGFR, and hs-CRP in the multivariate
model (Table 3). To be specific, in model 4, we found ahigh value for muscle strength in the second UA quar-
tile as compared with the first quartile, although the
difference was not significant. Meanwhile, both grip
strength and leg extension power were found to be sig-
nificantly lower across the latter 3 quartiles of serum
UA levels (P for linear trend = 0.05) (data not shown).
Discussion
Our population-based cross-sectional study has demon-
strated that hyperuricemia is associated with poor muscle
strength after adjustment for potential confounders in
Figure 1 Adjusted association between hyperuricemia and poor muscle strength. Adjusted for age, body mass index, education levels,
occupation, smoking status, drinking frequency, physical activity, daily energy intakes, daily protein intakes, metabolic syndrome, depressive
symptoms, estimated glomerular filtration rate, and high-sensitivity C-reactive protein. Data are shown as geometric means (grip strength), or
mean (leg extension power) and 95% confidence interval.
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have found a significant inverted J-shaped curve between
serum UA quartiles and muscle strength.
To the best of our knowledge, this study shows for the
first time that muscle strength was much lower in persons
with hyperuricemia than in those without hyperuricemia.
This study supports previous findings of low relative skel-
etal muscle mass in persons with hyperuricemia, which
reported that participants with serum UA levels >8 mg/dL
had 2 times the risk of sarcopenia (assessed on the basis of
skeletal muscle mass) compared with those with <6 mg/
dL after adjustment for other covariates in a population of
40 years old and older [29]. In addition, the observed
inverted J-shaped associations of serum UA levels with
muscle strength in our investigation were in accordance
with another cross-sectional population study in which
966 elderly subjects were analyzed [16]. The study showed
that participants in the middle serum UA quintile tended
to have less disability in instrumental activities of daily
living and better lower extremity function than those with
higher or lower UA levels. Although these results are
cross-sectional, keeping serum UA at an optimal level
may contribute to maintaining skeletal muscle mass. It is
interesting to note that most of the epidemiologic studies
have indicated that serum UA levels showed a J-shapedFigure 2 Univariate inverted J-shaped association of quartiles of seru
means (grip strength), or mean (leg extension power) and 95% confidenceassociation with cardiovascular events [11] and all-cause
mortality [30,31], implying that both a low and a high UA
level may lead to a higher risk of cardiovascular event or
mortality.
On the other hand, a most recent prospective cohort
study was the first to report a linear association of circu-
lating UA levels with grip strength or/and leg extension
power in elderly persons during a 3-year follow-up period
[10]. Given its powerful antioxidant capacity, UA may pro-
tect skeletal muscle function from ROS-induced protein
oxidative damage. However, the data in that study were
unable to demonstrate the negative impact of high UA
levels on muscle strength, as shown here. The different re-
sults between these 2 studies may be due to the disparity
in age in the sample populations studied. It is logical to
hypothesize that the antioxidant role of UA might be
more relevant in older subjects than in younger subjects
because the skeletal muscles in elderly persons have re-
duced overall antioxidant capacity to counteract ROS [32].
Moreover, another explanation is that the mean level (SD)
of serum UA is 6.1 (1.2) mg/dL in this study, which is
higher than the 5.0 (1.2) mg/dL (in both men and women)
from the previous study. It is well known that an increased
UA level is related to high inflammatory cytokines [14], a
contributor to poor muscle strength [33].m uric acid with muscle strength. Data are shown as geometric
interval.
Table 3 Multivariate adjusted mean values (95% confidence interval) of muscle strength by serum UA quartiles
Serum UA quartiles, mg/dL P 1 P 2
<5.4 5.4–6.0 6.1–6.8 >6.8
Grip strength, kg *
Participants (n = 586) 152 144 145 145 ― ―
Model 1 3 41.1 (40.1–42.1) 42.1 (41.1–43.2) 41.8 (40.8–42.8) 40.9 (39.9–42.0) 0.74 0.07
Model 2 4 41.2 (40.2–42.3) 42.1 (41.0–43.1) 41.8 (40.8–42.9) 40.8 (39.8–41.9) 0.55 0.09
Model 3 5 41.6 (40.6–42.7) 42.2 (41.1–43.2) 41.8 (40.8–42.9) 40.3 (39.2–41.3) 0.07 0.04
Model 4 6 41.6 (40.6–42.6) 42.2 (41.2–43.2) 41.8 (40.8–42.8) 40.4 (39.3–41.4) 0.09 0.05
Leg extension power, W/kg
Participants (n = 355) 92 90 85 88 ― ―
Model 1 18.1 (17.2–18.9) 19.2 (18.3–20.0) 18.8 (18.0–19.7) 18.3 (17.4–19.2) 0.84 0.06
Model 2 18.0 (17.2–18.9) 19.2 (18.4–20.1) 18.8 (17.9–19.7) 18.2 (17.4–19.1) 0.95 0.05
Model 3 18.3 (17.5–19.1) 19.2 (18.4–20.1) 18.9 (18.0–19.7) 17.9 (17.0–18.8) 0.43 0.03
Model 4 18.3 (17.5–19.2) 19.2 (18.4–20.1) 18.9 (18.1–19.8) 17.9 (17.0–18.8) 0.40 0.03
1 P for linear trend.
2 P for quadratic trend.
3 Adjusted for age and BMI.
4 Same as model 1 + education levels, occupation, smoking status, drinking frequency, physical activity, daily energy intake, and daily protein intake.
5 Same as model 2 +metabolic syndrome, depressive symptoms, and eGFR.
6 Same as model 3 + hs-CRP.
* Variables have been log-transformed and expressed as geometric means (95% confidence interval).
Abbreviations: BMI Body mass index, eGFR Estimated glomerular filtration rate, hs-CRP High-sensitivity C-reactive protein.
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http://www.biomedcentral.com/1471-2474/14/258In the current study, higher UA levels were associated
with poor grip strength and leg extension power by the
following possible mechanisms. First, elevated UA con-
centrations are related positively to systemic inflamma-
tion, particularly in the highest category of serum UA
[14]. Indeed, urate crystals contribute to the inflamma-
tory response through the release of pro-inflammatory
mediators [34], and the risk of urate crystal formation/
precipitation increases when the UA concentration ex-
ceeds 6.3 mg/dL [35]. As a prominent marker of sys-
temic chronic inflammation, CRP has been associated
with poor muscle strength [33,36,37]. Likewise, Cesari
et al. [33] and Barbieri et al. [38] reported that the pro-
inflammatory cytokine interleukin-6 (IL-6), which can
promote CRP synthesis [39], is an independent predictor
of poor muscle strength, especially in subjects with high
IL-6 blood levels. In this study, however, the results of
an inverted J-shaped curve between serum UA and muscle
strength did not appreciably change after additional
adjustment for hs-CRP, suggesting that inflammation is
not the principal mechanism mediating this association
among Japanese adult men. Second, the negative impact
of high UA concentrations on muscle strength may be
largely due to the serum UA-induced pro-oxidant capacity
at higher than normal levels. The antioxidant compound
UA may become pro-oxidant when concentrations reach
hyperuricemic levels, and the surrounding oxidant milieu,
acidity, or the depletion of other local antioxidants may
regulate the antioxidant/pro-oxidant switch [17]. In fact,serum carbonylated protein and skin advanced glycation
end products, which are widespread indicators of oxida-
tive damage, have been associated with poor muscle
strength in humans [40,41].
In addition, there is one hypothesis that may explain
the lower muscle strength observed in the first UA quar-
tile. A low serum UA level may reflect a decreased anti-
oxidant capability, as UA was considered an important
antioxidant in the blood [6-9]. Moreover, it is worth not-
ing that adjustment for daily energy and protein intakes
did not change the results of our study. These data seem
to exclude the possibility of a role of malnutrition in the
link, although low UA level may be a marker of low nu-
trient status [30], which was associated with poor grip
strength [42].
Although this study has revealed important insights
into the association between serum UA levels and muscle
strength, it does have limitations. First, the association be-
tween serum UA and muscle strength is temporarily due
to the cross-sectional nature of this study, and thus, a pro-
spective study is necessary to confirm the causality of this
association further. Second, we did not perform direct
measurement of the UA antioxidant capacity as well as
the total antioxidant capacity in the collected samples.
Third, because we could not ascertain the site of inflam-
mation in the present study, systemic or chronic inflam-
mation may be present independent of serum UA. Last,
the analysis was carried out only in men, and thus, our re-
sults cannot be directly generalized to women.
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Our cross-sectional study has, for the first time, revealed
a negative impact of hyperuricemia on grip strength and
leg extension power among Japanese men, after adjust-
ment for additional covariates. Furthermore, the current
study demonstrated that the association between serum
UA levels (quartiles) and muscle strength does not show
a linear trend but an inverted J-shaped curve. Future re-
search should focus on clarifying the causality in associ-
ation between circulating UA levels and muscle strength.
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